These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29351404)

  • 1. Type 2 diabetes impairs the ability of skeletal muscle pericytes to augment postischemic neovascularization in db/db mice.
    Hayes KL; Messina LM; Schwartz LM; Yan J; Burnside AS; Witkowski S
    Am J Physiol Cell Physiol; 2018 May; 314(5):C534-C544. PubMed ID: 29351404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice.
    Yan J; Tie G; Wang S; Messina KE; DiDato S; Guo S; Messina LM
    J Am Heart Assoc; 2012 Dec; 1(6):e002238. PubMed ID: 23316315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.
    Yan J; Tie G; Park B; Yan Y; Nowicki PT; Messina LM
    J Vasc Surg; 2009 Dec; 50(6):1412-22. PubMed ID: 19837544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia.
    Emanueli C; Caporali A; Krankel N; Cristofaro B; Van Linthout S; Madeddu P
    Front Biosci; 2007 Jan; 12():2003-12. PubMed ID: 17127438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoA-I Nanotherapy Rescues Postischemic Vascular Maladaptation by Modulating Endothelial Cell and Macrophage Phenotypes in Type 2 Diabetic Mice.
    Babu M; Devi D; Mäkinen P; Örd T; Aavik E; Kaikkonen M; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):e46-e61. PubMed ID: 36384268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
    Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus.
    Carr CL; Qi Y; Davidson B; Chadderdon S; Jayaweera AR; Belcik JT; Benner C; Xie A; Lindner JR
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2526-33. PubMed ID: 21885854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27(kip1) Knockout enhances collateralization in response to hindlimb ischemia.
    Ankri-Eliahoo G; Weitz K; Cox TC; Tang GL
    J Vasc Surg; 2016 May; 63(5):1351-9. PubMed ID: 25701497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericyte-Specific Ninjurin1 Deletion Attenuates Vessel Maturation and Blood Flow Recovery in Hind Limb Ischemia.
    Minoshima A; Kabara M; Matsuki M; Yoshida Y; Kano K; Tomita Y; Hayasaka T; Horiuchi K; Saito Y; Aonuma T; Nishimura M; Maruyama K; Nakagawa N; Sawada J; Takehara N; Hasebe N; Kawabe JI
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2358-2370. PubMed ID: 30354207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease.
    Kundu N; Domingues CC; Chou C; Ahmadi N; Houston S; Jerry DJ; Sen S
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28365567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Collateral Vessel Formation in Sickle Cell Disease.
    Okwan-Duodu D; Hansen L; Joseph G; Lyle AN; Weiss D; Archer DR; Taylor WR
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1125-1133. PubMed ID: 29545241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel model of chronic limb ischemia to therapeutically evaluate the angiogenic effects of drug candidates.
    Shimatani K; Sato H; Saito A; Sasai M; Watanabe K; Mizukami K; Kamohara M; Miyagawa S; Sawa Y
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1124-H1135. PubMed ID: 33481698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressed hindlimb perfusion in Rac2-/- and Nox2-/- mice does not result from impaired collateral growth.
    Distasi MR; Case J; Ziegler MA; Dinauer MC; Yoder MC; Haneline LS; Dalsing MC; Miller SJ; Labarrere CA; Murphy MP; Ingram DA; Unthank JL
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H877-86. PubMed ID: 19151256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-2 pericytes participate in normal and tumoral angiogenesis.
    Birbrair A; Zhang T; Wang ZM; Messi ML; Olson JD; Mintz A; Delbono O
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C25-38. PubMed ID: 24788248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of myeloperoxidase increases revascularization and improves blood flow in a diabetic mouse model of hindlimb ischaemia.
    Weihrauch D; Martin DP; Jones D; Krolikowski J; Struve J; Naylor S; Pritchard KA
    Diab Vasc Dis Res; 2020; 17(3):1479164120907971. PubMed ID: 32223319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerase δ-interacting protein 2 promotes postischemic neovascularization of the mouse hindlimb.
    Amanso AM; Lassègue B; Joseph G; Landázuri N; Long JS; Weiss D; Taylor WR; Griendling KK
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1548-55. PubMed ID: 24855063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia.
    Clayton JA; Chalothorn D; Faber JE
    Circ Res; 2008 Oct; 103(9):1027-36. PubMed ID: 18802023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against vascular aging in Nox2-deficient mice: Impact on endothelial progenitor cells and reparative neovascularization.
    Turgeon J; Haddad P; Dussault S; Groleau J; Maingrette F; Perez G; Rivard A
    Atherosclerosis; 2012 Jul; 223(1):122-9. PubMed ID: 22658259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice.
    Stabile E; Burnett MS; Watkins C; Kinnaird T; Bachis A; la Sala A; Miller JM; Shou M; Epstein SE; Fuchs S
    Circulation; 2003 Jul; 108(2):205-10. PubMed ID: 12821542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network.
    Schiekofer S; Galasso G; Sato K; Kraus BJ; Walsh K
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1603-9. PubMed ID: 15920034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.